About DrugAbuse Sciences
DrugAbuse Sciences is a company based in Menlo Park (United States) founded in 1994 was acquired by Elbion in January 2007.. DrugAbuse Sciences offers products and services including Naltrexone Depot and Addiction Medications. DrugAbuse Sciences operates in a competitive market with competitors including Indivior, Biotie, Ethypharm, Braeburn and Opiant Pharmaceuticals, among others.
- Headquarter Menlo Park, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Drugabuse Sciences, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DrugAbuse Sciences
DrugAbuse Sciences offers a comprehensive portfolio of products and services, including Naltrexone Depot and Addiction Medications. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Injection for treating alcohol dependence and reducing cravings.
Develops drugs to address substance abuse disorders.
Funding Insights of DrugAbuse Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DrugAbuse Sciences
DrugAbuse Sciences has secured backing from 1 investor. Prominent investors backing the company include Elbion. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Small molecules for CNS and inflammatory diseases were discovered.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DrugAbuse Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DrugAbuse Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Drugabuse Sciences Comparisons
Competitors of DrugAbuse Sciences
DrugAbuse Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indivior, Biotie, Ethypharm, Braeburn and Opiant Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for opioid addiction treatment are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Drugs for neurodegenerative and psychiatric disorders are developed by Biotie.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
|
| domain | founded_year | HQ Location |
Long-acting therapies for opioid addiction and chronic pain are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for addictive and eating disorders are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for substance use disorders are developed by Amygdala Neurosciences.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about DrugAbuse Sciences
When was DrugAbuse Sciences founded?
DrugAbuse Sciences was founded in 1994.
Where is DrugAbuse Sciences located?
DrugAbuse Sciences is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
What does DrugAbuse Sciences do?
DrugAbuse Sciences was founded in 1994 in Menlo Park, United States, as a specialty pharmaceutical company focused on addiction treatments. Therapies targeting alcohol, opiate, cocaine, and heroin dependencies are developed and commercialized. Key products include Naltrexone Depot for alcohol and opiate addictions, DAS-431 for cocaine addiction, and Buprenorphine for heroin and opiate use. Company assets were acquired by Elbion in January 2007, now integrated into Biotie.
Who are the top competitors of DrugAbuse Sciences?
DrugAbuse Sciences's top competitors include Indivior, Ethypharm and Amygdala Neurosciences.
What products or services does DrugAbuse Sciences offer?
DrugAbuse Sciences offers Naltrexone Depot and Addiction Medications.
Who are DrugAbuse Sciences's investors?
DrugAbuse Sciences has 1 investor. Key investors include Elbion.